Psychedelic-Induced Neural Plasticity: A Comprehensive Review and a Discussion of Clinical Implications
Brain Sciences · 25.01.2025 · 15 (2) · 117
DOI: 10.3390/brainsci15020117 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Brain Sciences, online erschienen am 25.01.2025. Verfasst von Francesco Weiss und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Via Roma 57, 56100 Pisa, Italy. Die Arbeit wurde bisher 69-mal zitiert (Crossref) und nennt 142 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Psychedelics are increasingly recognized as a promising and innovative treatment strategy for several mental disorders. However, there is still a lively controversy in the medical community as regards the rationale of their employment, specifically their indications and potential dangers.
Methods
A comprehensive literature search on “MEDLINE/PubMed” and “Web of Science” was performed from inception to 26 June 2024, cross-checking the obtained references. We included all studies, i.e., both clinical and preclinical, that supplied original data.
Results
We initially obtained a total of 1083 entries, 813 from MEDLINE/PubMed and 270 from Web of Science. After duplicate elimination, 903 underwent systematic literature selection. Primary abstract screening yielded a total of 572 candidates for eligibility assessment and excluded 331 entries on formal grounds. Eligibility assessment led to the exclusion of 501 titles. Finally, a total of 70 articles were included in this review.
Discussion
Preclinical evidence from genetic expression, histology and behavioral studies is soundly consistent with psychedelics possessing neuroplasticity-inducing properties. Despite methodological difficulties, clinical evidence seems to be inferentially in agreement with preclinical findings. However, it is still unclear whether the “neuroplastic boost” induced by classic psychedelics might be dissociable from the psychodysleptic effects, thereby reducing the psychopathological hazards implied by these compounds. Moreover, the fact that the so-called “relaxation of priors” should be unconditionally beneficial appears debatable, and further research should clarify the possible indications and contraindications of psychedelic psychoplastogens within a precision medicine perspective.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Via Roma 57, 56100 Pisa, Italy.
ORCID-Profile: Francesco Weiss, Anna Magnesa, Matteo Gambini, Riccardo Gurrieri, Eric Annuzzi, Camilla Elefante, Giulio Perugi, Donatella Marazziti
Zitieren
APA
Weiss, F., Magnesa, A., Gambini, M., Gurrieri, R., Annuzzi, E., Elefante, C., Perugi, G., & Marazziti, D. (2025). Psychedelic-Induced Neural Plasticity: A Comprehensive Review and a Discussion of Clinical Implications. Brain Sciences, 15(2), 117. https://doi.org/10.3390/brainsci15020117
Vancouver
Weiss F, Magnesa A, Gambini M, Gurrieri R, Annuzzi E, Elefante C, et al. Psychedelic-Induced Neural Plasticity: A Comprehensive Review and a Discussion of Clinical Implications. Brain Sciences. 2025;15(2):117. doi:10.3390/brainsci15020117
BibTeX
@article{Weiss2025,
author = {Weiss, Francesco and Magnesa, Anna and Gambini, Matteo and Gurrieri, Riccardo and Annuzzi, Eric and Elefante, Camilla and Perugi, Giulio and Marazziti, Donatella},
title = {Psychedelic-Induced Neural Plasticity: A Comprehensive Review and a Discussion of Clinical Implications},
journal = {Brain Sciences},
year = {2025},
volume = {15},
number = {2},
pages = {117},
doi = {10.3390/brainsci15020117}
}
EUVIMED